EQS-CMS: Fresenius Medical Care AG : Release of a capital market information

Fresenius Medical Care AG: Share buyback  Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014 Share buyback – Interim Report In the period from July 20th, 2026, to July 24th, 2026 (each inclusive), 241,000 shares were bought back within the framework of the second tranche of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on January 12, 2026, pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052. Shares were bought back as follows:

Date	Acquired shares (number)	Weighted average price (in EUR)	Transaction volume (in EUR)	Trading venue
20 July 2026	75,000	42.3216	3,174,120.00	XETR
21 July 2026	25,000	42.6177	1,065,442.50	XETR
22 July 2026	1,000	43.0354	43,035.40	XETR
23 July 2026	70,000	42.5677	2,979,739.00	XETR
24 July 2026	70,000	42.9602	3,007,214.00	XETR

A total of 3,535,040 shares has been acquired within the framework of the second tranche of the share buyback. The purchase of the shares is carried out by a credit institution commissioned by Fresenius Medical Care AG. Fresenius Medical Care AG will provide regular information regarding the progress of the share buyback, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/.